These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19893995)

  • 81. Collaborative study on saccharide quantification of the
    Rosskopf U; Daas A; Terao E; von Hunolstein C
    Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines.
    Shearer MH; Lucas AH; Anderson PW; Carey KD; Jenson HB; Chanh TC; Stanley JR; Kennedy RC
    Infect Immun; 1997 Aug; 65(8):3267-70. PubMed ID: 9234785
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009.
    Ladhani S; Ramsay M; Flood J; Campbell H; Slack M; Pebody R; Findlow J; Newton E; Wilding M; Warrington R; Crawford H; Min S; Gray K; Martin S; Frankland S; Bokuvha N; Laher G; Borrow R
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171823
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines.
    Crowley-Luke A; Reddin K; Gorringe A; Hudson MJ; Robinson A
    Vaccine; 2001 May; 19(25-26):3399-407. PubMed ID: 11348704
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis.
    Lee H; Hahn S; Lee HJ; Kim KH
    J Korean Med Sci; 2010 Jan; 25(1):90-6. PubMed ID: 20052353
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.
    Hetherington SV; Patrick CC
    Infect Immun; 1992 Jan; 60(1):19-24. PubMed ID: 1729183
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial.
    Kukkonen K; Nieminen T; Poussa T; Savilahti E; Kuitunen M
    Pediatr Allergy Immunol; 2006 Sep; 17(6):416-21. PubMed ID: 16925686
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine.
    Mäkelä PH; Käyhty H; Leino T; Auranen K; Peltola H; Ekström N; Eskola J
    Vaccine; 2003 Dec; 22(2):287-92. PubMed ID: 14615157
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.
    Fusco PC; Michon F; Laude-Sharp M; Minetti CA; Huang CH; Heron I; Blake MS
    Vaccine; 1998 Nov; 16(19):1842-9. PubMed ID: 9795390
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.
    Hamidi A; Kreeftenberg H
    Hum Vaccin Immunother; 2014; 10(9):2697-703. PubMed ID: 25483494
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Characterization of the antibody response to a Haemophilus influenzae type b conjugate vaccine in children with recurrent lower respiratory tract infection.
    Kristensen K; Barington T; Pressler T; Heilmann C
    Allergy; 1995 Jun; 50(6):528-31. PubMed ID: 7573850
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine.
    Rutstein RM; Rudy BJ; Cnaan A
    Arch Pediatr Adolesc Med; 1996 Aug; 150(8):838-41. PubMed ID: 8704891
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Haemophilus type B conjugate vaccine: postimmunization kinetics of IgM and IgG antibody responses in ten vaccinated children.
    Vincent-Ballereau F; Lafaix C; Claudel-Daniel V; Hessel L; Benyayer P; Auget JL
    Vaccine; 1994 Apr; 12(5):403-5. PubMed ID: 8023547
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory.
    Granoff DM; Lucas AH
    Ann N Y Acad Sci; 1995 May; 754():278-88. PubMed ID: 7625664
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Functional activities of human antibody induced by the capsular polysaccharide or polysaccharide-conjugate vaccines against Haemophilus influenzae type b.
    Deveikis A; Ward J; Kim KS
    Vaccine; 1988 Feb; 6(1):14-8. PubMed ID: 3258459
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls.
    Avanzini MA; Carrà AM; Maccario R; Zecca M; Zecca G; Pession A; Comoli P; Bozzola M; Prete A; Esposito R; Bonetti F; Locatelli F
    J Clin Immunol; 1998 May; 18(3):193-201. PubMed ID: 9624578
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology.
    Herrmann DJ; Hamilton RG; Barington T; Frasch CE; Arakere G; Mäkelä O; Mitchell LA; Nagel J; Rijkers GT; Zegers B
    J Immunol Methods; 1992 Apr; 148(1-2):101-14. PubMed ID: 1564320
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay.
    Whitelegg AM; Birtwistle J; Richter A; Campbell JP; Turner JE; Ahmed TM; Giles LJ; Fellows M; Plant T; Ferraro AJ; Cobbold M; Drayson MT; MacLennan CA
    J Immunol Methods; 2012 Mar; 377(1-2):37-46. PubMed ID: 22293629
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.
    Ojo-Amaize EA; Church JA; Barka NE; Agopian MS; Peter JB
    Clin Diagn Lab Immunol; 1995 May; 2(3):286-90. PubMed ID: 7664173
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.
    Ambrosino DM; Umetsu DT; Siber GR; Howie G; Goularte TA; Michaels R; Martin P; Schur PH; Noyes J; Schiffman G
    J Allergy Clin Immunol; 1988 Jun; 81(6):1175-9. PubMed ID: 3259962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.